These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


534 related items for PubMed ID: 26887775

  • 1. [Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer].
    Li Z, Wang Q, Zhang W, Yang Z, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):854-60. PubMed ID: 26887775
    [Abstract] [Full Text] [Related]

  • 2. [Effect of XPG down-regulation gene expression towards the proliferation of epithelial ovarian cancer cells and its chemosensitivity to platinum].
    Zhang W, Wu FX, Wang Q, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):286-91. PubMed ID: 22781116
    [Abstract] [Full Text] [Related]

  • 3. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].
    Chen J, Wang Q, Zhang W, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482
    [Abstract] [Full Text] [Related]

  • 4. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J, Wang Q, Zhang W, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr 25; 51(4):285-92. PubMed ID: 27116987
    [Abstract] [Full Text] [Related]

  • 5. [Biological effects of upregulated expression of transfected FOLR1 gene on SKOV3 cell lines acted by cisplatin].
    Huang MJ, Zhang W, Wang Q, Cai ZA, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Sep 25; 48(9):676-82. PubMed ID: 24332135
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Role of microRNA-21 in the proliferation and apoptosis of ovarian epithelial carcinoma cells].
    Lou YH, Cui ZM, Wang FL, Yang XS.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep 25; 46(9):684-9. PubMed ID: 22176994
    [Abstract] [Full Text] [Related]

  • 8. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P, Zhang X, Liu H, Chen L.
    DNA Cell Biol; 2015 Jul 25; 34(7):497-502. PubMed ID: 25941922
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of CXCL1 gene expression on the biological function of epithelial ovarian carcinoma cells in vitro].
    Zhang W, Huang N, Wang Q, Yang ZJ, Li L.
    Zhonghua Zhong Liu Za Zhi; 2013 Feb 25; 35(2):109-13. PubMed ID: 23714664
    [Abstract] [Full Text] [Related]

  • 14. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.
    Zhang R, Shi H, Ren F, Li X, Zhang M, Feng W, Jia Y.
    Oncol Rep; 2016 Apr 25; 35(4):2466-72. PubMed ID: 26794135
    [Abstract] [Full Text] [Related]

  • 15. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
    Qin L, Qiu H, Zhang M, Zhang F, Yang H, Yang L, Jia L, Qin K, Jia L, Dou X, Cheng L, Sang M, Zhang C, Shan B, Zhang Z.
    Biomed Pharmacother; 2016 Apr 25; 79():166-75. PubMed ID: 27044825
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Significance of circadian gene Period2 expression in epithelial ovarian cancer and the effect of gene overexpression on growth of ovarian cancer xenografts in nude mice].
    Wang Z, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jun 25; 50(6):446-51. PubMed ID: 26311553
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.